The Structural Heart division is at the forefront of innovation in the field of cardiovascular care, focusing on a comprehensive portfolio of life‑changing technologies. Abbott is committed to transforming the treatment landscape for patients with structural heart disease through its robust array of therapies such as Transcatheter Mitral and Tricuspid Interventions (TMTI), Transcatheter Aortic Valve Implantation (TAVI), and solutions for stroke risk reduction and congenital heart disease and surgical heart valves. This division has been a key revenue driver in the EMEA region, with its continuous double‑digit growth since 2017. The Structural Heart division not only includes cutting‑edge technologies but also maintains focus on traditional areas like mitral valve repair and congenital heart disease. This diverse approach ensures continued attention to profitability and market share, reinforcing Abbott's role as a leader in cardiovascular solutions.
This General Manager position is responsible for leading the organization’s strategic direction and financial performance in Italy for the Structural Heart Division across all its franchises (Mitraclip, Triclip, TAVR, Tendyne, Structural Intervention, Cardiac Surgery). It oversees sales operations and marketing execution to drive growth and market success. Ensures business activities align with corporate policies while adhering to local legal, regulatory, and cultural standards. Collaborates closely with finance, regulatory/quality, clinical, HR, communications, legal, and IT teams to support seamless operations and strategic objectives.